Announced Thu, 30 Apr · 18:29 IST

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.1%1-day move
₹25.50
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-1.4+4.9+15.5+12.4+20.1+14.7+10.2-8.0
Up moveDown movePending
AI summary

Bandaram Pharma Packtech Ltd has filed an Initial Disclosure with BSE clarifying that it does not qualify as a 'Large Corporate' under SEBI's framework (Circular dated October 19, 2023). The company meets only one of the three required criteria — having equity shares listed on BSE. It does not meet the other two conditions: outstanding long-term borrowings of ₹1,000 crore or more, and possession of credit rating 'AA' or above for unsupported bank borrowings or plain vanilla bonds. Therefore, the Initial Disclosure requirement for financial year 2026–2027 is not applicable to the company. The disclosure was signed by Chairman and Managing Director B. Deepak Reddy.

Likely market impact

No direct impact on shareholders — this is a routine compliance filing confirming the company is not classified as a Large Corporate and is therefore exempt from additional disclosure obligations under SEBI guidelines.